Terms: = Head and neck cancer AND MYCN, N-myc, 4613, ENSG00000134323, NMYC, MODED, ODED AND Treatment
20 results:
1. Posttreatment complications in pediatric cervical neuroblastoma: A retrospective case series at a tertiary cancer center.
Lopez J; Subramanian T; Durell J; Levyn H; Wong R; Shah J; LaQuaglia MP; Gerstle JT
J Surg Oncol; 2024 Feb; 129(2):219-223. PubMed ID: 37850570
[TBL] [Abstract] [Full Text] [Related]
2. A multi-institutional epidemiologic study evaluating environmental risk factors for feline oral squamous cell carcinoma.
Noall L; Lee S; Burton JH; Marquardt TM; Cermak J; Thombs LA; Rogic AM; Bryan JN; Chu S
Vet Comp Oncol; 2023 Sep; 21(3):509-519. PubMed ID: 37243409
[TBL] [Abstract] [Full Text] [Related]
3. GSK2801 Reverses Paclitaxel Resistance in Anaplastic Thyroid cancer Cell Lines through mycn Downregulation.
Molteni E; Baldan F; Damante G; Allegri L
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36983070
[TBL] [Abstract] [Full Text] [Related]
4. Inhibition of cyclin-dependent kinases by AT7519 enhances nasopharyngeal carcinoma cell response to chemotherapy.
Wei X; Nian J; Zheng J; He Y; Zeng M
Cancer Chemother Pharmacol; 2020 May; 85(5):949-957. PubMed ID: 32279103
[TBL] [Abstract] [Full Text] [Related]
5. Long-term prognosis of low-risk neuroblastoma treated by surgery alone: an experience from a single institution of China.
Yao W; Li K; Dong KR; Zheng S; Xiao XM
World J Pediatr; 2019 Apr; 15(2):148-152. PubMed ID: 30446974
[TBL] [Abstract] [Full Text] [Related]
6. Analysis of the risk factor for the poor prognosis of localized neuroblastoma after the surgical.
Zhou K; Li XL; Pan J; Xu JZ; Wang J
Medicine (Baltimore); 2018 Oct; 97(40):e12718. PubMed ID: 30290678
[TBL] [Abstract] [Full Text] [Related]
7. The MYB/miR-130a/NDRG2 axis modulates tumor proliferation and metastatic potential in salivary adenoid cystic carcinoma.
Wang Y; Zhang CY; Xia RH; Han J; Sun B; Sun SY; Li J
Cell Death Dis; 2018 Sep; 9(9):917. PubMed ID: 30206227
[TBL] [Abstract] [Full Text] [Related]
8. Caffeic Acid Phenethyl Ester Induces
Chiang KC; Yang SW; Chang KP; Feng TH; Chang KS; Tsui KH; Shin YS; Chen CC; Chao M; Juang HH
Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29738439
[TBL] [Abstract] [Full Text] [Related]
9. Identification of novel biomarker and therapeutic target candidates for diagnosis and treatment of follicular carcinoma.
Lai X; Umbricht CB; Fisher K; Bishop J; Shi Q; Chen S
J Proteomics; 2017 Aug; 166():59-67. PubMed ID: 28709933
[TBL] [Abstract] [Full Text] [Related]
10. Caffeic acid phenethyl ester upregulates n-myc downstream regulated gene 1 via ERK pathway to inhibit human oral cancer cell growth in vitro and in vivo.
Chung LC; Chiang KC; Feng TH; Chang KS; Chuang ST; Chen YJ; Tsui KH; Lee JC; Juang HH
Mol Nutr Food Res; 2017 Sep; 61(9):. PubMed ID: 28181403
[TBL] [Abstract] [Full Text] [Related]
11. The Iron Chelator, Dp44mT, Effectively Inhibits Human Oral Squamous Cell Carcinoma Cell Growth in Vitro and in Vivo.
Lee JC; Chiang KC; Feng TH; Chen YJ; Chuang ST; Tsui KH; Chung LC; Juang HH
Int J Mol Sci; 2016 Aug; 17(9):. PubMed ID: 27589737
[TBL] [Abstract] [Full Text] [Related]
12. mycn-mediated miR-21 overexpression enhances chemo-resistance via targeting CADM1 in tongue cancer.
Zheng G; Li N; Jia X; Peng C; Luo L; Deng Y; Yin J; Song Y; Liu H; Lu M; Zhang Z; Gu Y; He Z
J Mol Med (Berl); 2016 Oct; 94(10):1129-1141. PubMed ID: 27055844
[TBL] [Abstract] [Full Text] [Related]
13. Overexpression of NDRG2 Increases Iodine Uptake and Inhibits Thyroid Carcinoma Cell Growth In Situ and In Vivo.
Yin A; Wang C; Sun J; Gao J; Tao L; Du X; Zhao H; Yang J; Li Y
Oncol Res; 2016 Jan; 23(1-2):43-51. PubMed ID: 26802650
[TBL] [Abstract] [Full Text] [Related]
14. Influence of image-defined risk factors on the outcome of patients with localised neuroblastoma. A report from the LNESG1 study of the European International Society of Paediatric Oncology Neuroblastoma Group.
Monclair T; Mosseri V; Cecchetto G; De Bernardi B; Michon J; Holmes K
Pediatr Blood Cancer; 2015 Sep; 62(9):1536-42. PubMed ID: 25663103
[TBL] [Abstract] [Full Text] [Related]
15. Multidisciplinary management of cervical neuroblastoma in infants.
Csanády M; Vass G; Bartyik K; Majoros V; Rovó L
Int J Pediatr Otorhinolaryngol; 2014 Dec; 78(12):2103-6. PubMed ID: 25306308
[TBL] [Abstract] [Full Text] [Related]
16. Outcomes of children with intermediate-risk neuroblastoma after treatment stratified by mycn status and tumor cell ploidy.
Bagatell R; Rumcheva P; London WB; Cohn SL; Look AT; Brodeur GM; Frantz C; Joshi V; Thorner P; Rao PV; Castleberry R; Bowman LC
J Clin Oncol; 2005 Dec; 23(34):8819-27. PubMed ID: 16314642
[TBL] [Abstract] [Full Text] [Related]
17. Primary pediatric neuroblastic tumors of the neck.
Moukheiber AK; Nicollas R; Roman S; Coze C; Triglia JM
Int J Pediatr Otorhinolaryngol; 2001 Aug; 60(2):155-61. PubMed ID: 11518594
[TBL] [Abstract] [Full Text] [Related]
18. Risk-based management: current concepts of treating malignant solid tumors of childhood.
Grosfeld JL
J Am Coll Surg; 1999 Oct; 189(4):407-25. PubMed ID: 10509467
[TBL] [Abstract] [Full Text] [Related]
19. Cervical neuroblastoma and multiple endocrine neoplasia type 2a.
Triglia JM; Bernard JL; Scheiner C
Int J Pediatr Otorhinolaryngol; 1993 Feb; 26(1):71-7. PubMed ID: 8095252
[TBL] [Abstract] [Full Text] [Related]
20. Establishment and characterization of a cell line of congenital primitive neuroectodermal tumor of soft tissue.
Fukushige T; Nagoshi M; Hachitanda Y; Ueno T; Zaizen Y; Suita S; Tsuneyoshi M; Kaneko Y; Nakagawara A
Virchows Arch B Cell Pathol Incl Mol Pathol; 1992; 62(3):159-66. PubMed ID: 1357816
[TBL] [Abstract] [Full Text] [Related]
